Scope Biosciences
Scope Biosciences is a on-site development platform technology specializing in the development of molecular diagnostics using CRISPR-Cas.
Scope Biosciences has raised €1.5M across 3 funding rounds from 4 investors, most recently a round in Jun 2025. Based in Wageningen, Netherlands; active in Healthtech. Data as of 28 Oct 2026.
Wageningen, Netherlandswww.scopebio.com ↗
Total raised
€1.5M
€1,500,000
Funding rounds
3
Investors
4
distinct backers
Active since
2021-11
latest 2025-06
Funding by year
EUR raised per yearScope Biosciences — funding by year — interactive chart.
Data table
| Scope Biosciences — funding by year | |
|---|---|
| 2021 | €1.0M |
| 2023 | €500k |
| 2025 | €0 |
Signals
High confidenceRaise-next likelihood36
base rate 30% for Other
- ▲ In typical raise window
- ▼ Down/flat last round
- ▼ Low backer re-investment
Exit likelihood13
base rate 11% (2+ rounds)
- ▲ 5y since founding (typical exit age)
- ▲ Recent equity round, but funding momentum is down (may be rescue financing)
Timing: in window vs cohort gap · momentum down. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
3 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2025-06-16 | Other | — | Oost NL,SHIFT Invest | View deal → |
| 2023-10-25 | Other | €500k | Oost NL,SHIFT Invest | View deal → |
| 2021-11-16 | Other | €1.0M | GenDx | View deal → |
Investors
4Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- Picnic€1.7BNetherlands · E-commerce
- Just Eat Takeaway€1.6BNetherlands · Foodtech
- Nebius€1.5BNetherlands · Cloud
- CMR Surgical€1.5BUK · Healthtech
Global coverage: FundingData